BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 24136988)

  • 1. The molecular balancing act of p16(INK4a) in cancer and aging.
    LaPak KM; Burd CE
    Mol Cancer Res; 2014 Feb; 12(2):167-83. PubMed ID: 24136988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.
    Romagosa C; Simonetti S; López-Vicente L; Mazo A; Lleonart ME; Castellvi J; Ramon y Cajal S
    Oncogene; 2011 May; 30(18):2087-97. PubMed ID: 21297668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
    Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
    J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16
    Novais EJ; Diekman BO; Shapiro IM; Risbud MV
    Matrix Biol; 2019 Sep; 82():54-70. PubMed ID: 30811968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γ-Tocotrienol prevents cell cycle arrest in aged human fibroblast cells through p16
    Zainuddin A; Chua KH; Tan JK; Jaafar F; Makpol S
    J Physiol Biochem; 2017 Feb; 73(1):59-65. PubMed ID: 27743340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.
    Burd CE; Sorrentino JA; Clark KS; Darr DB; Krishnamurthy J; Deal AM; Bardeesy N; Castrillon DH; Beach DH; Sharpless NE
    Cell; 2013 Jan; 152(1-2):340-51. PubMed ID: 23332765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.
    Liu Y; Johnson SM; Fedoriw Y; Rogers AB; Yuan H; Krishnamurthy J; Sharpless NE
    Blood; 2011 Mar; 117(12):3257-67. PubMed ID: 21245485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.
    Villuendas R; Sánchez-Beato M; Martínez JC; Saez AI; Martinez-Delgado B; García JF; Mateo MS; Sanchez-Verde L; Benítez J; Martínez P; Piris MA
    Am J Pathol; 1998 Sep; 153(3):887-97. PubMed ID: 9736037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of p16
    Khatiwala RV; Zhang S; Li X; Devejian N; Bennett E; Cai C
    Stem Cell Rev Rep; 2018 Aug; 14(4):612-625. PubMed ID: 29675777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species promotes cellular senescence in normal human epidermal keratinocytes through epigenetic regulation of p16(INK4a.).
    Sasaki M; Kajiya H; Ozeki S; Okabe K; Ikebe T
    Biochem Biophys Res Commun; 2014 Sep; 452(3):622-8. PubMed ID: 25181340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a.
    Alani RM; Young AZ; Shifflett CB
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7812-6. PubMed ID: 11427735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer.
    Zhao R; Choi BY; Lee MH; Bode AM; Dong Z
    EBioMedicine; 2016 Jun; 8():30-39. PubMed ID: 27428416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.
    Helman A; Klochendler A; Azazmeh N; Gabai Y; Horwitz E; Anzi S; Swisa A; Condiotti R; Granit RZ; Nevo Y; Fixler Y; Shreibman D; Zamir A; Tornovsky-Babeay S; Dai C; Glaser B; Powers AC; Shapiro AM; Magnuson MA; Dor Y; Ben-Porath I
    Nat Med; 2016 Apr; 22(4):412-20. PubMed ID: 26950362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney.
    Melk A; Schmidt BM; Vongwiwatana A; Rayner DC; Halloran PF
    Am J Transplant; 2005 Jun; 5(6):1375-82. PubMed ID: 15888044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of p16INK4a and low expression of Bmi1 are associated with endothelial cellular senescence in the human cornea.
    Wang Y; Zang X; Wang Y; Chen P
    Mol Vis; 2012; 18():803-15. PubMed ID: 22509111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of p16(INK4a) to replicative senescence of human fibroblasts.
    Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G
    Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SATB2, coordinated with CUX1, regulates IL-1β-induced senescence-like phenotype in endothelial cells by fine-tuning the atherosclerosis-associated p16
    Wu T; Wu Y; Jiang D; Sun W; Zou M; Vasamsetti SB; Dutta P; Leers SA; Di W; Li G
    Aging Cell; 2023 Feb; 22(2):e13765. PubMed ID: 36633253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREG1 enhances p16(INK4a) -induced cellular senescence.
    Moolmuang B; Tainsky MA
    Cell Cycle; 2011 Feb; 10(3):518-30. PubMed ID: 21263217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli.
    Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin II; Leonova KI; Consiglio CR; Gollnick SO; Chernova OB; Gudkov AV
    Aging (Albany NY); 2017 Aug; 9(8):1867-1884. PubMed ID: 28768895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.